Calciphylaxis in kidney graft recipient with type 1 diabetes: A case report
- Authors: Polykova V.V.1, Matezius I.Y.1, Fomina E.V.1, Lopatin Z.V.1, Semenova E.V.1, Ulyankina I.V.2,3
-
Affiliations:
- North-Western State Medical University named after I.I. Mechnikov
- Academician I.P. Pavlov First St. Petersburg State Medical Universitya
- Saint Petersburg Scientific Research Institute of Emergency Medicine named after. I.I. Dzhanelidze
- Issue: Vol 27, No 3 (2023)
- Pages: 43-54
- Section: Case report
- Submitted: 02.08.2023
- Accepted: 21.08.2023
- Published: 08.11.2023
- URL: https://journals.eco-vector.com/RFD/article/view/567966
- DOI: https://doi.org/10.17816/RFD567966
- ID: 567966
Cite item
Abstract
Calcifylaxis — calcifying uremic arteriolopathy — is a rare disease that occurs in patients with chronic kidney disease and is characterized by progressive calcification of small-caliber skin vessels and thrombosis of small (arterioles), accompanied by necrosis of the skin, subcutaneous tissue and soft tissues with severe pain syndrome. The article describes a patient with a long-term, severe course of diabetes mellitus, the development of diabetic nephropathy with an outcome in terminal renal failure, which required renal replacement therapy with peritoneal dialysis and kidney transplantation. In the posttransplantation period, the patient registered the occurrence of calcifylaxis, which is a rare complication.
The lack of treatment protocols for calcifylaxis in patients with chronic kidney disease requires further research. It is important to constantly monitor patients with risk factors for the development of this serious disease and timely treatment, which will improve their condition and slow down the progression of the process.
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Valentina V. Polykova
North-Western State Medical University named after I.I. Mechnikov
Email: valentina.polyakova@szgmu.ru
ORCID iD: 0000-0001-9148-4546
md, cand. sci. (med.), assistant professor
Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015Irina Yu. Matezius
North-Western State Medical University named after I.I. Mechnikov
Email: imatezius@yandex.ru
ORCID iD: 0000-0002-8694-9756
md, cand. sci. (med.), assistant professor
Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015Elizaveta V. Fomina
North-Western State Medical University named after I.I. Mechnikov
Email: 4891190@mail.ru
ORCID iD: 0009-0002-4905-1573
Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015
Zakhar V. Lopatin
North-Western State Medical University named after I.I. Mechnikov
Email: zakhar.lopatin@szgmu.ru
ORCID iD: 0000-0001-7283-9911
md, cand. sci. (med.), assistant professor
Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015Elena V. Semenova
North-Western State Medical University named after I.I. Mechnikov
Email: elenalokb@yandex.ru
ORCID iD: 0000-0003-2955-9097
md, cand. sci. (med.), assistant professor
Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015Irina V. Ulyankina
Academician I.P. Pavlov First St. Petersburg State Medical Universitya; Saint Petersburg Scientific Research Institute of Emergency Medicine named after. I.I. Dzhanelidze
Author for correspondence.
Email: spb.yl@mail.ru
ORCID iD: 0000-0001-9207-520X
md, cand. sci. (med.)
Russian Federation, Saint-PetersburgReferences
- Podestà MA, Ciceri P, Galassi A, Cozzolino M. Calciphylaxis after kidney transplantation: a rare but life-threatening disorder. Clin Kidney J. 2022;15(4):611–614. doi: 10.1093/ckj/sfab247
- Abbas H, Alotaibi M, Lebron R. A case report: Calciphylaxis presenting as digital ischemia in patient with end stage kidney disease on peritoneal dialysis. Open J Nephrol. 2019;9:49–53. doi: 10.4236/ojneph.2019.92006
- Nigwekar SU, Zhao S, Wenger J, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 2016;27(11):3421–3429. doi: 10.1681/ASN.2015091065
- Baby D, Upadhyay M, Joseph MD, et al. Calciphylaxis and its diagnosis. J Family Med Prim Care. 2019;8(9):2763–2767. doi: 10.4103/jfmpc.jfmpc_588_19
- Ryan MP, Ross LS. Calciphylaxis after kidney transplant. Cureus. 2019;11(5):e4695. doi: 10.7759/cureus.4695
- Gabel CK, Nguyen ED, Chakrala T, et al. Assessment of outcomes of calciphylaxis. J Am Acad Dermatol. 2021;85(4):1057–1064. doi: 10.1016/j.jaad.2020.10.067
- Shuman H, Obri MS, Artz C, et al. Nonuremic calciphylaxis precipitated by COVID-19 infection. Cureus. 2022;14(3):e22796. doi: 10.7759/cureus.22796
- Nigwekar SU, Kroshinsky D, Nazarian RM, et al. Calciphylaxis: risk factors, diagnosis, and treatmen. Am J Kidney Dis. 2015;66(1):133–146. doi: 10.1053/j.ajkd.2015.01.034
- Guillén E, Torregrosa JV, Garcia-Herrera A, et al. Development of calciphylaxis in kidney transplant recipients with a functioning graft. Clin Kidney J. 2021;15(4):663–671. doi: 10.1093/ckj/sfab205
- Nefrologiya. Klinicheskie rekomendatsii. Ed. by E.M. Shilov, A.V. Smirnov, N.L. Kozlovskaya. Moscow; 2019. P. 736–740 p. (In Russ.)
- Brandenburg V, Adragao T, van Dam B, et al. Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet). Clin Kidney J. 2015;8:567–571. doi: 10.1093/ndt/gfv438
- Nigwekar SU, Zhao S, Wenger J, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 2016;27:3421–3429. doi: 10.1681/ASN.2015091065
- Brandenburg VM, Kramann R, Rothe H, et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant. 2017;32(1):126–132. doi: 10.1093/ndt/gfv438
- Udomkarnjananun S, Kongnatthasate K, Praditpornsilpa K, et al. Treatment of calciphylaxis in CKD: a systematic review and meta-analysis. Kidney Int Rep. 2018;4(2):231–244. doi: 10.1016/j.ekir.2018.10.002
- Kodumudi V, Jeha GM, Mydlo N, Kaye AD. Management of cutaneous calciphylaxis. Adv Ther. 2020;37(12):4797–4807. doi: 10.1007/s12325-020-01504-w
- Gaisne R, Péré M, Menoyo V, et al. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study. BMC Nephrol. 2020;21(1):63. doi: 10.1186/s12882-020-01722-y
- Jeong HS, Dominguez AR. Calciphylaxis: controversies in pathogenesis, diagnosis and treatment. Am J Med Sci. 2016;351(2):217–227. doi: 10.1016/j.amjms.2015.11.015
- Sinha S, Gould LJ, Nigwekar SU, et al. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J. 2022;15:136–144. doi: 10.1093/ckj/sfab117
- Ricardo VB, Egido J. Phosphate, pyrophosphate, and vascular calcification: a question of balance. Eur Heart J. 2017;38(23):1801–1804. doi: 10.1093/eurheartj/ehv605
- Egshatyan LV, Mokrysheva NG. Ectopic calcification in chronic kidney disease. Part 1. Classification and pathogenesis. Nephrology (Saint-Petersburg). 2017;21(4):30–39. (In Russ.) doi: 10.24884/1561-6274-2017-21-4-30-39
- Ruderman I, Toussaint ND, Hawley CM, et al. The Australian calciphylaxis registry: reporting clinical features and outcomes of patients with calciphylaxis. Nephrol Dial Transplant. 2021;36:649–656. doi: 10.1093/ndt/gfz256
- Musso CG, Enz PA, Kowalczuk A, et al. Differential diagnosis of calciphylaxis in chronic dialysis patients. Int Urol Nephrol. 2020;52(3):595–597. doi: 10.1007/s11255-020-02388-z
- Westphal SG, Plumb T. Calciphylaxis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
- Yu WY, Bhutani T, Kornik R, et al. Warfarin-associated nonuremic calciphylaxis. JAMA Dermatol. 2017;153(3):309–314. doi: 10.1001/jamadermatol.2016.4821
- Cianciolo G, Capelli I, Angelini ML, et al. Importance of vascular calcification in kidney transplant recipients. Am J Nephrol. 2014;39:418–426. doi: 10.1159/000362492
- Ponticelli C, Glassock RJ. Prevention of complications from use of conventional immunosuppressants: a critical review. J Nephrol. 2019;32(6):851–870. doi: 10.1007/s40620-019-00602-5
- Guillén E, Torregrosa JV, Garcia-Herrera A, et al. Development of calciphylaxis in kidney transplant recipients with a functioning graft. Clin Kidney J. 2022;15(4):663–671. doi: 10.1093/ckj/sfab205
Supplementary files
![](/img/style/loading.gif)